Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(1.20)
# 3,458
Out of 4,349 analysts
50
Total ratings
37.1%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintained: Buy | $250 → $270 | $213.94 | +26.20% | 7 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $240 → $200 | $142.65 | +40.20% | 4 | May 7, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $50.84 | -1.65% | 6 | May 7, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $11.51 | +73.76% | 2 | May 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Buy | $62 → $55 | $43.07 | +27.70% | 7 | May 5, 2026 | |
| RGEN Repligen | Rated: Buy | $170 → $140 | $122.73 | +14.07% | 8 | Apr 6, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $170 → $118 | $67.83 | +73.96% | 5 | Apr 6, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $72.34 | -6.00% | 1 | Nov 26, 2025 | |
| GH Guardant Health | Maintained: Buy | $68 → $90 | $133.22 | -32.44% | 4 | Oct 30, 2025 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $321.80 | - | 6 | Oct 27, 2025 |
Natera
May 8, 2026
Maintained: Buy
Price Target: $250 → $270
Current: $213.94
Upside: +26.20%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $240 → $200
Current: $142.65
Upside: +40.20%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $50.84
Upside: -1.65%
MiniMed Group
May 6, 2026
Maintained: Buy
Price Target: $20
Current: $11.51
Upside: +73.76%
Inspire Medical Systems
May 5, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $43.07
Upside: +27.70%
Repligen
Apr 6, 2026
Rated: Buy
Price Target: $170 → $140
Current: $122.73
Upside: +14.07%
TransMedics Group
Apr 6, 2026
Maintained: Buy
Price Target: $170 → $118
Current: $67.83
Upside: +73.96%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $72.34
Upside: -6.00%
Guardant Health
Oct 30, 2025
Maintained: Buy
Price Target: $68 → $90
Current: $133.22
Upside: -32.44%
West Pharmaceutical Services
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $321.80
Upside: -